Changing epidemiology of respiratory syncytial virus in Australia — delayed re-emergence in Victoria compared to WA/NSW after prolonged lock-down for COVID-19. Clin Infect Dis 2021 Mar 18 ...

1. Borchers AT et coll. Respiratory syncytial virus—a comprehensive review. Clin. Rev. Allergy Immunol. 2013 ; 45 : 331–379. 2. Kwong JC et coll. Acute myocardial infarction after laboratory ...

Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease ...

Palivizumab, when given through the veins or into a muscle (systemically), reduces hospitalisations due to respiratory syncytial virus (RSV) and reduces respiratory problems later on (chest wheezing), ...

Déployer plus largement la vaccination contre l’infection à VRS (virus respiratoire syncytial), dont l’impact, depuis son ...

The risk for respiratory syncytial virus-related hospitalizations is elevated in children with chronic medical conditions ...

Incidence of respiratory syncytial virus infection among hospitalized adults, 2017-2020. Clin Infect Dis 2022;74(6):1004-1011. 9 . Belongia EA, King JP, Kieke BA, et al.

Despite adequate availability of nirsevimab, only about one third of eligible children receive it for respiratory syncytial virus prophylaxis, with uptake varying by race and other social factors.

A new respiratory syncytial virus vaccine to protect infants from severe illness is available in South Africa’s private ...

An RSV vaccine has been available to pregnant women in Northern Ireland since last September and is offered from 28 weeks of ...